Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2017
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasFrancesco Abate, Ana C da Silva-Almeida, Sakellarios Zairis, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Medicine|December 4, 2019
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Nature|August 19, 2014
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemiaPanagiotis Ntziachristos, Aristotelis Tsirigos, G Grant Welstead, et al.
Blood|October 8, 2015
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemiasNicole Kucine, Sachie Marubayashi, Neha Bhagwat, et al.
Blood Advances|October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell LymphomaJ Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2016
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemiaKoichi Oshima, Hossein Khiabanian, Ana C da Silva-Almeida, et al.
Blood Advances|January 24, 2022
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort studyJ Erika Haydu, Jenny S Maron, Robert A Redd, et al.
Pageof 12